Cetraxal

Cetraxal is a brand name of ciprofloxacin otic, approved by the FDA in the following formulation(s):

CETRAXAL (ciprofloxacin hydrochloride - solution/drops; otic)

• 
  Manufacturer: WRASER PHARMS
  
  Approval date: May 1, 2009
  
  Strength(s): EQ 0.2% BASE ^[RLD]

Has a generic version of Cetraxal been approved?

No. There is currently no therapeutically equivalent version of Cetraxal available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Cetraxal. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Cetraxal.

Related Exclusivities

Exclusivity is exclusive marketing rights granted by the FDA upon approval of a drug and can run concurrently with a patent or not. Exclusivity is a statutory provision and is granted to an NDA applicant if statutory requirements are met.

• Exclusivity expiration dates:
  • May 1, 2012 - NEW DOSAGE FORM
  
  

See also...

• Cetraxal Consumer Information (Drugs.com)
• Cetraxal Ear Drops Consumer Information (Wolters Kluwer)
• Cetraxal Consumer Information (Cerner Multum)
• Cetraxal Advanced Consumer Information (Micromedex)
• Ciprofloxacin Ear Drops Consumer Information (Wolters Kluwer)
• Ciprofloxacin otic Consumer Information (Cerner Multum)
• Ciprofloxacin Otic Advanced Consumer Information (Micromedex)